Meeker David Pinsider trades
In SEC Form 4 filings, Meeker David P is listed as President and CEO of Rhythm Pharmaceuticals, Inc. (RYTM). In the last 90 days, Meeker David P sold $5.13M of Rhythm Pharmaceuticals, Inc. (RYTM) on the open market and bought none. All 5 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | President and CEO | 7 | Sep 14 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-14
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | M | 50,000 | $6.05 | $302,500 | 289,258 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | S | 6,439 | $101.75 | Sale −$655,145 | 282,819 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | S | 30,746 | $102.35 | Sale −$3,146,761 | 252,073 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | S | 8,698 | $103.43 | Sale −$899,634 | 243,375 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | S | 1,817 | $104.55 | Sale −$189,965 | 241,558 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | S | 2,300 | $105.19 | Sale −$241,937 | 239,258 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Sep 14 | Sep 14 | M · derivative | 50,000 | $6.05 | $302,500 | 15,431 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.